Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 72

Sort by

Sort Order Select

Journal Articles

Sirolimus Combined with Cyclosporine (CSP) and Mycophenolate Mofetil (MMF) As Graft-Vs-Host Disease (GVHD) Prophylaxis after Nonmyeloablative (NMA) Hematopoietic Cell Transplantation (HCT) Using HLA Class I or Class II Antigen Mismatched Donors: Results from a Phase II Multi-Center Trial

Brian Kornblit, MD PhD, Barry Storer, Michael B. Maris, MD, Niels Smedegaard Andersen, MD PhD, Thomas R. Chauncey, MD PhD, Effie W. Petersdorf, MD, Ann Woolfrey, MD, David G. Maloney, MD PhD, Rainer Storb, MD, Brenda M Sandmaier, MD

Blood (2019) 134 (Supplement_1): 369.

https://doi.org/10.1182/blood-2019-123196

Published: 2019

Journal Articles

Post-Transfusion Overall Survival for HLA- Alloimmunized Platelet Refractorythrombocytopenic Leukemia Patients

Maliha Khan, Courtney D. DiNardo, MDMSc, Denái R. Milton, Musa Yilmaz, MD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Benjamin Lichtiger, MD PhD, Fleur M. Aung, MD

Blood (2017) 130 (Supplement 1): 4924.

https://doi.org/10.1182/blood.V130.Suppl_1.4924.4924

Published: 2017

Journal Articles

Downregulation of MHC Class II in Relapsed AML Cells after Allogeneic Transplantation

Blood (2017) 130 (Supplement 1): 2678.

https://doi.org/10.1182/blood.V130.Suppl_1.2678.2678

Published: 2017

Journal Articles

Maria: Accurate Prediction of MHC-II Peptide Presentation with Deep-Learning and Lymphoma Patient MHC-II Ligandome

Binbin Chen, BS, Michael Khodadoust, MD PhD, Niclas Olsson, PhD, Ethan Fast, BS, Lisa E Wagar, PhD, Chih Long Liu, PhD, Mark Davis, PhD, Ronald Levy, MD, Joshua E Elias, PhD, Russ B Altman, MD PhD, Arash A. Alizadeh, MD PhD

Blood (2017) 130 (Supplement 1): 1486.

https://doi.org/10.1182/blood.V130.Suppl_1.1486.1486

Published: 2017

Journal Articles

Mapping the HLA Ligandome Landscape of Chronic Myeloid Leukemia Identifies Novel CD8 + and CD4 + T Cell-Epitopes for Immunotherapeutic Approaches

Tatjana Bilich, Annika Nelde, Daniel J. Kowalewski, Janet Peper, Mirle Schemionek, PhD, Lothar Kanz, MD, Helmut R. Salih, MD, Tim H. Brümmendorf, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 4232.

https://doi.org/10.1182/blood.V128.22.4232.4232

Published: 2016

Journal Articles

Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin's Lymphoma (NHL)

Blood (2016) 128 (22): 464.

https://doi.org/10.1182/blood.V128.22.464.464

Published: 2016

Journal Articles

HLA Ligandome Analysis of Different Hematological Malignancies Identifies a Small Panel of "Pan-Leukemia"-Associated Antigens

Linus Backert, Daniel J. Kowalewski, Simon D. Walz, Heiko Schuster, Claudia Berlin, Mirle Schemionek, PhD, Tim H. Brümmendorf, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Lothar Kanz, MD, Helmut R. Salih, MD, Katja Weisel, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 2169.

https://doi.org/10.1182/blood.V128.22.2169.2169

Published: 2016

Journal Articles

Interferon Gamma (IFNγ)/STAT1 Signaling in Host Antigen Present Cells Suppresses MHC Class II-Dependent Presentation of Self-Antigens and Development of Graft Versus Host Disease (GVHD)

Caisheng Lu, MD PhD, Huihui Ma, MD, PhD, Liangsong Song, MD, PhD, Shirong Li, PhD, Suzanne Lentzsch, MD PhD, Markus Y Mapara, MD PhD

Blood (2016) 128 (22): 2147.

https://doi.org/10.1182/blood.V128.22.2147.2147

Published: 2016

Journal Articles

Low Expression of the CIITA Gene Predicts Poor Outcome in Diffuse Large B-Cell Lymphoma

Matias Autio, MS, Kirsi Jäntti, PhD, Alejandra Cervera, MSc, Sampsa Hautaniemi, Professor, Sirpa Leppä, MD PhD

Blood (2016) 128 (22): 2948.

https://doi.org/10.1182/blood.V128.22.2948.2948

Published: 2016

Journal Articles

A Phase I/II Trial of Vorinostat (SAHA) in Combination with Rituximab-CHOP in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL): SWOG S0806

Daniel O. Persky, MD, Hongli Li, PhD, Lisa M. Rimsza, MD, Paul M. Barr, MD, Leslie L. Popplewell, MD, Charles L. Bane, MD, Ann Von Gehr, MD, Michael Leblanc, PhD, Richard I. Fisher, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD MMSc

Blood (2015) 126 (23): 3931.

https://doi.org/10.1182/blood.V126.23.3931.3931

Published: 2015

Journal Articles

T Cell Activation By Plasmacytoid Dendritic Cells Is Augmented By Inhibition of Vasoactive Intestinal Polypeptide Signaling: Implications for Cellular Immunotherapy

Jingxia Li, Reema Panjwani, Jian-Ming Li, PhD, Cynthia R. Giver, PhD, Maryellen Malone, Edmund K Waller, MD PhD

Blood (2015) 126 (23): 3438.

https://doi.org/10.1182/blood.V126.23.3438.3438

Published: 2015

Journal Articles

Factor VIII gene variants and inhibitor risk in African American hemophilia A patients

Devi Gunasekera, Ruth A. Ettinger, Shelley Nakaya Fletcher, Eddie A. James, Maochang Liu, John C. Barrett, Janice Withycombe, Dana C. Matthews, Melinda S. Epstein, Richard J. Hughes, Kathleen P. Pratt

Blood (2015) 126 (7): 895–904.

https://doi.org/10.1182/blood-2014-09-599365

Published: 2015

Includes: Supplemental data

Journal Articles

Genetic Alterations of the MHC Class II Transactivator CIITA Are Frequent in Primary Mediastinal Large B-Cell Lymphoma and Associated with Diminished MHC Class II Expression

Anja Mottok, MD, Bruce W. Woolcock, MSc, Fong Chun Chan, MSc, Adele Telenius, MSc, Elizabeth A. Chavez, Cg R.T, Merrill Boyle, B.Sc., Susana Ben-Neriah, MSc, Lisa M. Rimsza, MD, Reiner Siebert, MD, Randy D. Gascoyne, MD, Christian Steidl, MD

Blood (2014) 124 (21): 3040.

https://doi.org/10.1182/blood.V124.21.3040.3040

Published: 2014

Journal Articles

HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma

Dorota Jesionek-Kupnicka, MD PhD, Marcin Bojo, MD PhD, Monika Prochorec-Sobieszek, MD PhD, Anna Szumera-Cieckiewicz, MD PhD, Joanna Jablonska, MD PhD, Ewa Kalinka-Warzocha, MD PhD, Radzislaw Kordek, MD PhD, Wojciech Mlynarski, MDPhD, Tadeusz Robak, MD, Krzysztof Warzocha, MD PhD, Ewa Lech-Maranda, MD PhD

Blood (2014) 124 (21): 1642.

https://doi.org/10.1182/blood.V124.21.1642.1642

Published: 2014

Journal Articles

Donor Requirements For CD4+CD25+FoxP3+ Regulatory T Cells Capable Of Suppressing CD4+ and CD8+ Conventional T Cell Proliferation and Graft Versus Host Disease

Antonio Pierini, MD, Lucrezia Colonna, PhD, Maite Alvarez, PhD, Dominik Schneidawind, MD, Byung-Su Kim, MD, Jeanette Baker, PhD, Robert Negrin, MD

Blood (2013) 122 (21): 4484.

https://doi.org/10.1182/blood.V122.21.4484.4484

Published: 2013

Journal Articles

Antithymocyte Globulin (Rabbit) Enhanced The Efficacy Of Tacrolimus and Mycophenolate For Graft-Versus-Host Disease Prophylaxis In Recipients Of Unrelated Stem Cell Transplant Resulting In Improvement Of Survival

Voravit Ratanatharathorn, MD, Abhinav Deol, MD, Lois Ayash, MD, Divaya Bhutani, MD, Lawrence G Lum, MD, DSc, Zaid Al-Kadhimi, MD, Muneer H. Abidi, MD, Marie Ventimiglia, Kendra Mellert, Joseph P. Uberti, MD, PhD

Blood (2013) 122 (21): 3300.

https://doi.org/10.1182/blood.V122.21.3300.3300

Published: 2013

Journal Articles

MicroRNA-146a regulates survival and maturation of human plasmacytoid dendritic cells

Julien J. Karrich, Loes C. M. Jachimowski, Marion Libouban, Anand Iyer, Kim Brandwijk, Esther W. Taanman-Kueter, Maho Nagasawa, Esther C. de Jong, Christel H. Uittenbogaart, Bianca Blom

Blood (2013) 122 (17): 3001–3009.

https://doi.org/10.1182/blood-2012-12-475087

Published: 2013

Includes: Supplemental data

Journal Articles

Antibodies Specific for MHC Class II Antigens Cause TRALI Directly in a Two-Event in Vivo Model

Marguerite R Kelher, MS, Christopher C. Silliman, MD, PhD

Blood (2012) 120 (21): 845.

https://doi.org/10.1182/blood.V120.21.845.845

Published: 2012

Journal Articles

Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma

Sarah T. Wilkinson, Kristie A. Vanpatten, Diane R. Fernandez, Patrick Brunhoeber, Karl E. Garsha, Betty J. Glinsmann-Gibson, Thomas M. Grogan, Julie Teruya-Feldstein, Lisa M. Rimsza

Blood (2012) 119 (6): 1459–1467.

https://doi.org/10.1182/blood-2011-07-363820

Published: 2012

Journal Articles

Characterization of Packed Red Blood Cells Prepared with Experimental Multifunctional Leukocyte and Antibody-Reduction Filters

Christopher C Silliman, MD/PhD, Marguerite R Kelher, MS, Monica LaSarre, MT(ASCP)SBB, Travis H Berry, Kadi Schroeder, BSN, MBA, Tuan Le, MD, D. Joe Chaffin, MD, Kevin J Land, MD, Barbara Mish, BS, Linda Ceriano, AS, Samuel O. Sowemimo-Coker, PhD

Blood (2011) 118 (21): 2320.

https://doi.org/10.1182/blood.V118.21.2320.2320

Published: 2011

NARROW

Sirolimus Combined with Cyclosporine (CSP) and Mycophenolate Mofetil (MMF) As Graft-Vs-Host Disease (GVHD) Prophylaxis after Nonmyeloablative (NMA) Hematopoietic Cell Transplantation (HCT) Using HLA Class I or Class II Antigen Mismatched Donors: Results from a Phase II Multi-Center Trial

Post-Transfusion Overall Survival for HLA- Alloimmunized Platelet Refractorythrombocytopenic Leukemia Patients

Downregulation of MHC Class II in Relapsed AML Cells after Allogeneic Transplantation

Maria: Accurate Prediction of MHC-II Peptide Presentation with Deep-Learning and Lymphoma Patient MHC-II Ligandome

Mapping the HLA Ligandome Landscape of Chronic Myeloid Leukemia Identifies Novel CD8 + and CD4 + T Cell-Epitopes for Immunotherapeutic Approaches

Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin's Lymphoma (NHL)

HLA Ligandome Analysis of Different Hematological Malignancies Identifies a Small Panel of "Pan-Leukemia"-Associated Antigens

Interferon Gamma (IFNγ)/STAT1 Signaling in Host Antigen Present Cells Suppresses MHC Class II-Dependent Presentation of Self-Antigens and Development of Graft Versus Host Disease (GVHD)

Low Expression of the CIITA Gene Predicts Poor Outcome in Diffuse Large B-Cell Lymphoma

A Phase I/II Trial of Vorinostat (SAHA) in Combination with Rituximab-CHOP in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL): SWOG S0806

T Cell Activation By Plasmacytoid Dendritic Cells Is Augmented By Inhibition of Vasoactive Intestinal Polypeptide Signaling: Implications for Cellular Immunotherapy

Factor VIII gene variants and inhibitor risk in African American hemophilia A patients

Genetic Alterations of the MHC Class II Transactivator CIITA Are Frequent in Primary Mediastinal Large B-Cell Lymphoma and Associated with Diminished MHC Class II Expression

HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma

Donor Requirements For CD4+CD25+FoxP3+ Regulatory T Cells Capable Of Suppressing CD4+ and CD8+ Conventional T Cell Proliferation and Graft Versus Host Disease

Antithymocyte Globulin (Rabbit) Enhanced The Efficacy Of Tacrolimus and Mycophenolate For Graft-Versus-Host Disease Prophylaxis In Recipients Of Unrelated Stem Cell Transplant Resulting In Improvement Of Survival

MicroRNA-146a regulates survival and maturation of human plasmacytoid dendritic cells

Antibodies Specific for MHC Class II Antigens Cause TRALI Directly in a Two-Event in Vivo Model

Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma

Characterization of Packed Red Blood Cells Prepared with Experimental Multifunctional Leukocyte and Antibody-Reduction Filters

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only